BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:30 PM
Jul 18, 2007
 |  BC Extra  |  Clinical News

Dynavax to start Tolamba trial

DVAX said that next quarter it plans to start a 300-patient, placebo-controlled study of Tolamba for ragweed allergy following a $30 million loan commitment from Deerfield. Data from the...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >